Page last updated: 2024-09-05

a2-binding peptide and Esophageal Neoplasms

a2-binding peptide has been researched along with Esophageal Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Fujii, N; Imamura, M; Inoue, N; Kanaoka, S; Kaneko, M; Okino, T; Otaka, A; Shimada, Y; Yamasaki, S	1

Other Studies

1 other study(ies) available for a2-binding peptide and Esophageal Neoplasms

Article	Year
Induction of human leukocyte antigen (HLA)-A2-restricted and MAGE-3-gene-derived peptide-specific cytolytic T lymphocytes using cultured dendritic cells from an HLA-A2 esophageal cancer patient. Journal of surgical oncology, 1999, Volume: 71, Issue:1 Topics: Antigen-Presenting Cells; Antigens, Neoplasm; Dendritic Cells; Esophageal Neoplasms; HLA-A2 Antigen; Humans; Immunotherapy, Active; Intercellular Signaling Peptides and Proteins; Neoplasm Proteins; Peptides; Reverse Transcriptase Polymerase Chain Reaction; Tumor Cells, Cultured	1999

Article

Year

Induction of human leukocyte antigen (HLA)-A2-restricted and MAGE-3-gene-derived peptide-specific cytolytic T lymphocytes using cultured dendritic cells from an HLA-A2 esophageal cancer patient.

Journal of surgical oncology, 1999, Volume: 71, Issue:1

Topics: Antigen-Presenting Cells; Antigens, Neoplasm; Dendritic Cells; Esophageal Neoplasms; HLA-A2 Antigen; Humans; Immunotherapy, Active; Intercellular Signaling Peptides and Proteins; Neoplasm Proteins; Peptides; Reverse Transcriptase Polymerase Chain Reaction; Tumor Cells, Cultured

1999